In 2023, actual mortality from ischaemic heart diseases in the US stood at approximately 384.21 thousand deaths. Based on forecasted data from 2024 to 2028, a steady increase is expected with deaths climbing from 386.42 to 395.28 thousand, reflecting incremental growth year-on-year.
The year-on-year percentage increases are subtle, indicating minor variations:
- From 2024 to 2025: approximately 0.58% increase
- From 2025 to 2026: approximately 0.57% increase
- From 2026 to 2027: approximately 0.57% increase
- From 2027 to 2028: approximately 0.56% increase
Over the five-year forecast period, the compounded annual growth rate (CAGR) is approximately 0.57%.
Future trends to watch for include potential impacts of advancements in medical technology, public health initiatives aimed at reducing risk factors, and shifts in population demographics, which may alter the course of mortality rates associated with ischaemic heart diseases.
